|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The comparable operational sales growth reported by Abbott’s Nutrition segment in 4Q17 came in at ~2%. International sales performance has seen an improvement in 4Q17. With the new food safety regulations in effect from January 1, 2018, Abbott appears to be prepared for the transition and expects to see a minimal impact of these changes on its performance.
Will Marijuana Become Legally Available to Canadians? In the previous part of this series, we briefly discussed how the different active components of the cannabis plant make it a more complex product than tobacco and alcohol. There are hundreds of strains of cannabis plants. Naturally, companies selling cannabis products would spend heavily on educating customers to enable more informed decisions.
The chart above illustrates the market capitalization trends of marijuana companies versus bitcoin and other major companies. Plus, the recreational marijuana market has been picking up steam. To learn more about this market, please read Must-Knows before Investing in the Marijuana Industry.
In the previous part of this series, we touched on the illegal elements surrounding cryptocurrency and the marijuana industry. Marijuana is considered an illicit drug with a potential for abuse. As a result, it’s classified as a Schedule 1 drug in the US under federal law. Additionally, drug cartels have controlled the marijuana supply in North America, presenting an ongoing criminal problem for authorities.
With the marijuana sector heating up in Canada lately, we know that several existing and new companies will be rushing to capitalize on the opportunity. Canaccord Genuity, an investment banking company, has outlined the players by market share. The chart above shows that Canopy Growth Corporation (WEED) is expected to command the largest portion of the market (MJX) (HMLSF) share, or 14.6%, as an individual entity by 2021.
Investors are hesitant to put new money into capital markets right now because equity markets are at all-time highs, bond yields are near historically low levels and valuations are rich. We have been sorting through our universe to find opportunities we feel can achieve a positive total return.
Nestle may sell its roughly $900 million-a-year U.S. confectionery business, which includes Butterfinger and BabyRuth, in the Swiss food group's latest effort to improve the health profile of its sprawling portfolio.
Rating Action: Moody's upgrades Mead Johnson notes to A3 on Reckitt Benckiser guarantee. Global Credit Research- 15 Jun 2017. Approximately $3 billion of debt instruments affected.
Rating Action: Moody's downgrades Reckitt Benckiser's ratings to A3 and P-2; stable outlook. Global Credit Research- 13 Jun 2017. London, 13 June 2017-- Moody's Investors Service has today downgraded the ...
Mead Johnson Nutrition Company (MJN) and Reckitt Benckiser have cleared the final regulatory hurdle of their impending merger.
The U.K. consumer goods company looks to expand its footprint outside its core businesses and into developing markets in efforts to revamp its top line.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mead Johnson Nutrition Co. Here are 5 ETFs with the largest exposure to MJN-US. Comparing the performance and risk of Mead Johnson Nutrition Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Mead Johnson Nutrition Co. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of USD 883.50 million, Net Earnings of USD 119.20 million. Gross margins narrowed from 63.30% to 62.35% compared to the same period last year, operating (EBITDA) margins now 22.78% from 26.80%. Change in ... Read more (Read more...)
Mead Johnson Nutrition Company (MJN) reported first-quarter 2017 adjusted earnings per share (EPS) of 80 cents at constant exchange rate or CER, down 8% year over year.
Currently, Mead Johnson has a Zacks Rank #3 (Hold) but that could change following its first-quarter 2017 earnings report which has just released.
On a per-share basis, the Glenview, Illinois-based company said it had profit of 65 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to 80 cents per ...